June 23, 2023
June 23, 2023 - Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Litfulo (ritlecitinib), a once-daily oral treatment
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Health Insurance
June 22, 2023
June 22, 2023 - Sebela Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)
granted approval of Suflave TM
June 22, 2023
June 22, 2023 – Sarepta Therapeutics, Inc., announced U.S. Food and Drug Administration (FDA)
accelerated approval of Elevidys (delandistrogene moxeparvovec-rokl)
June 21, 2023
June 21, 2023 - Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application
June 20, 2023
June 20, 2023 - AGEPHA Pharma USA, LLC, has announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco®
June 20, 2023
June 20, 2023 - Halozyme Therapeutics, Inc. has announced that argenx received U.S. Food and Drug Administration (FDA) approval for Vyvgart® Hytrulo
June 15, 2023
June 15, 2023 - Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Columvi
June 13, 2023
June 13, 2023 - The Harvard Drug Group, LLC and Rugby Laboratories has initiated a voluntary recall of a
single lot of Dronabinol Capsules